EPISODE · Oct 6, 2022 · 9 MIN
Should these opioids be schedule 1 drugs?
from POLITICO's Pulse Check · host POLITICO
More than 100 researchers, scientists and public health professionals want fentanyl-related substances to no longer be Schedule I drugs — saying a different classification has the potential to unlock research on those drugs to treat opioid addiction or other mental health conditions. Daniel Payne and Ben Leonard unpack a Tuesday letter sent to the White House. Plus, Jason Gibbons, a postdoctoral fellow at Johns Hopkins University, explains a new study on using buprenorphine in Medicare patients. Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
More than 100 researchers, scientists and public health professionals want fentanyl-related substances to no longer be Schedule I drugs — saying a different classification has the potential to unlock research on those drugs to treat opioid addiction or other mental health conditions. Daniel Payne and Ben Leonard unpack a Tuesday letter sent to the White House. Plus, Jason Gibbons, a postdoctoral fellow at Johns Hopkins University, explains a new study on using buprenorphine in Medicare patients. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Should these opioids be schedule 1 drugs?
No transcript for this episode yet
Similar Episodes
Jun 20, 2026 ·2m
Jun 20, 2026 ·2m
Jun 15, 2026 ·3m
Jun 15, 2026 ·3m
Jun 14, 2026 ·2m
Jun 14, 2026 ·2m